Clinical Trials Browser

INDUSTRY × Breast Neoplasms × Immunoconjugates × Clear all

NCT04829604 2026-03-09

ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)

Phase 2 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT03255070 2024-02-01

A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)

Phase 1 Completed

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms